Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Primary screen of kinases in signalling pathway between Protease activated receptor 2 (PAR2) and the ion channels Transient receptor potential vanilloid-4 (TRPV4) in HEK293 cells
Assay data:91 Active, 714 Tested
Summary
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (COLO678)
Assay data:22 Active, 794 Tested
SummaryPubMed CitationRelated BioAssays by Depositor
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (DIFI)
Assay data:11 Active, 794 Tested
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (HT115)
Assay data:14 Active, 794 Tested
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (SW48)
Assay data:16 Active, 794 Tested
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (HCC56)
Assay data:20 Active, 794 Tested
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (NCIH630)
Assay data:17 Active, 794 Tested
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (LS513)
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (SNUC1)
Assay data:9 Active, 794 Tested
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (HT29)
Assay data:15 Active, 794 Tested
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (RCM1)
Assay data:13 Active, 794 Tested
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (HT55)
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (CAR1)
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (HCT15)
Assay data:18 Active, 794 Tested
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (SNUC5)
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (SW620)
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (SNU407)
Assay data:12 Active, 794 Tested
Inhibition of recombinant human MEK2 using fluorescein-labeled peptide as substrate by fluorescence-electrophoretic mobility shift assay
Assay data:1 Tested
SummaryRelated BioAssays by Target
Inhibition of MEK2 (unknown origin) at 1 uM by selectscreen kinase profiling assay in presence of ATP
SummaryPubMed CitationRelated BioAssays by Target
Inhibition of human MEK2 using ERK2 as substrate
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on